Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy

Elisa Habermann; Lutz Gieselmann; Pinkus Tober-Lau; Alexander ten Hagen; Fredrik N Albach; Jan Zernicke; Elvin Ahmadov; Amanthi Nadira Arumahandi de Silva; Leonie Maria Frommert; Jens Klotsche; Florian Kurth; Leif Erik Sander; Gerd Burmester; Florian Klein; Robert Biesen

doi:10.1101/2022.06.11.22276272

Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy

View ORCID ProfileElisa Habermann, View ORCID ProfileLutz Gieselmann, View ORCID ProfilePinkus Tober-Lau, View ORCID ProfileAlexander ten Hagen, View ORCID ProfileFredrik N Albach, View ORCID ProfileJan Zernicke, Elvin Ahmadov, View ORCID ProfileAmanthi Nadira Arumahandi de Silva, View ORCID ProfileLeonie Maria Frommert, View ORCID ProfileJens Klotsche, View ORCID ProfileFlorian Kurth, View ORCID ProfileLeif Erik Sander, View ORCID ProfileGerd Burmester, View ORCID ProfileFlorian Klein, View ORCID ProfileRobert Biesen

doi: https://doi.org/10.1101/2022.06.11.22276272

Elisa Habermann

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Elisa Habermann

Lutz Gieselmann

2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lutz Gieselmann

Pinkus Tober-Lau

3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pinkus Tober-Lau

Alexander ten Hagen

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alexander ten Hagen

Fredrik N Albach

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fredrik N Albach

Jan Zernicke

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jan Zernicke

Elvin Ahmadov

2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amanthi Nadira Arumahandi de Silva

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Amanthi Nadira Arumahandi de Silva

Leonie Maria Frommert

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Leonie Maria Frommert

Jens Klotsche

2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jens Klotsche

Florian Kurth

3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Florian Kurth

Leif Erik Sander

3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Leif Erik Sander

Gerd Burmester

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gerd Burmester

Florian Klein

2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

5German Center for Infection Research, Partner site Bonn-Cologne, Cologne, Germany

6Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Florian Klein

Robert Biesen

1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Robert Biesen
For correspondence: Robert.Biesen@charite.de

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data relevant to the study are included in the article. Data are available on reasonable request.

View the discussion thread.

PreviousNext

Posted June 14, 2022.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy

Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Alexander ten Hagen, Fredrik N Albach, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Jens Klotsche, Florian Kurth, Leif Erik Sander, Gerd Burmester, Florian Klein, Robert Biesen

medRxiv 2022.06.11.22276272; doi: https://doi.org/10.1101/2022.06.11.22276272

Share This Article: